Login to Your Account



Pharma: Other News To Note


Monday, December 17, 2012
• Bristol-Myers Squibb Co., of New York, joined the Multiple Myeloma Research Foundation pre-competitive consortium to discover and accelerate new approaches to treating multiple myeloma through the organization's Personalized Medicine Initiative.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription